PEDRO LICHTINGER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PEDRO LICHTINGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PEDRO LICHTINGER. PEDRO LICHTINGER is a Director in BIOTIME INC ($BTX) and a CEO and President in OPTIMER PHARMACEUTICALS INC ($OPTR) and a President & CEO in Asterias Biotherapeutics, Inc. ($ASTY) and a Director in Gemphire Therapeutics Inc. ($GEMP).
Address: 1301 HARBOR BAY PARKWAY ALAMEDA 94502 CA
Companies in which PEDRO LICHTINGER is an Insider
Asterias Biotherapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PEDRO LICHTINGER: President & CEO
Holdings: 0 shares
Latest Transaction: Jan 19 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Lineage Cell Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PEDRO LICHTINGER: Director
Holdings: 126,250 shares
Current Value: $386,325
Latest Transaction: Jul 03 2014
$BTX Market Capitalization: $309.34M
$BTX Previous Close: $3.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NeuroBo Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PEDRO LICHTINGER: Director
Holdings: 74,833 shares
Current Value: $802,210
Latest Transaction: Jul 26 2019
$NRBO Market Capitalization: $97.34M
$NRBO Previous Close: $10.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OPTIMER PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PEDRO LICHTINGER: CEO and President
Holdings: 93,078 shares
Latest Transaction: May 17 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PEDRO LICHTINGER
Sentiment: All, ASTY, BTX, NRBO, OPTR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 26 2019 | GEMP | Gemphire Therapeut ... | LICHTINGER PEDRO | Director | Grant | A | 0.00 | 15,000 | 0 | 74,833 | 59.8 K to 74.8 K (+25.07 %) |
| Jan 30 2018 | GEMP | Gemphire Therapeut ... | LICHTINGER PEDRO | Director | Option Exercise | A | 10.44 | 10,800 | 112,752 | 10,800 | |
| Mar 14 2017 | GEMP | Gemphire Therapeut ... | LICHTINGER PEDRO | Director | Option Exercise | P | 10.40 | 7,920 | 82,368 | 7,920 | |
| Mar 14 2017 | GEMP | Gemphire Therapeut ... | LICHTINGER PEDRO | Director | Buy | P | 9.47 | 10,559 | 99,994 | 59,833 | 49.3 K to 59.8 K (+21.43 %) |
| Aug 12 2016 | GEMP | Gemphire Therapeut ... | LICHTINGER PEDRO | Director | Buy | P | 10.00 | 10,000 | 100,000 | 49,274 | 39.3 K to 49.3 K (+25.46 %) |
| Aug 12 2016 | GEMP | Gemphire Therapeut ... | LICHTINGER PEDRO | Director | Buy | C | 6.71 | 39,274 | 263,368 | 39,274 | 0 to 39.3 K |
| Aug 08 2016 | GEMP | Gemphire Therapeut ... | LICHTINGER PEDRO | Director | Option Exercise | A | 10.00 | 60,000 | 600,000 | 60,000 |